市場調査レポート概要
目次
Description
Table of Contents
Figures
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2027 (% GROWTH) TABLE 2 VACCINE ADJUVANTS MARKET: IMPACT ANALYSIS TABLE 3 NIH FUNDING FOR VACCINE RESEARCH, 2019-2023 (USD MILLION) TABLE 4 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS (TOP 5) TABLE 5 AVERAGE SELLING PRICE OF ADJUVANT EMULSIONS TABLE 6 AVERAGE SELLING PRICE OF PARTICULATE ADJUVANTS TABLE 7 AVERAGE SELLING PRICE OF SAPONIN-BASED ADJUVANTS TABLE 8 SUPPLY CHAIN ECOSYSTEM TABLE 9 VACCINE ADJUVANTS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 14 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS TABLE 15 VACCINE ADJUVANTS MARKET: PORTER’S FIVE FORCES ANALYSIS TABLE 16 VACCINE ADJUVANTS MARKET: INDICATIVE LIST OF PATENTS TABLE 17 VACCINE ADJUVANTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 18 ADJUVANT EMULSIONS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 19 NORTH AMERICA: ADJUVANT EMULSIONS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 20 EUROPE: ADJUVANT EMULSIONS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 21 ASIA PACIFIC: ADJUVANT EMULSIONS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 22 PATHOGEN COMPONENTS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 23 NORTH AMERICA: PATHOGEN COMPONENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 24 EUROPE: PATHOGEN COMPONENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 25 ASIA PACIFIC: PATHOGEN COMPONENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 26 SAPONIN-BASED ADJUVANTS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 27 NORTH AMERICA: SAPONIN-BASED ADJUVANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 28 EUROPE: SAPONIN-BASED ADJUVANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 29 ASIA PACIFIC: SAPONIN-BASED ADJUVANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 30 PARTICULATE ADJUVANTS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 31 NORTH AMERICA: PARTICULATE ADJUVANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 32 EUROPE: PARTICULATE ADJUVANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 33 ASIA PACIFIC: PARTICULATE ADJUVANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 34 OTHER VACCINE ADJUVANTS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 35 NORTH AMERICA: OTHER VACCINE ADJUVANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 36 EUROPE: OTHER VACCINE ADJUVANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 37 ASIA PACIFIC: OTHER VACCINE ADJUVANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 38 VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) TABLE 39 ADVANTAGES AND DISADVANTAGES OF INTRAMUSCULAR ADMINISTRATION TABLE 40 VACCINE ADJUVANTS MARKET FOR INTRAMUSCULAR ADMINISTRATION, BY REGION, 2021-2028 (USD MILLION) TABLE 41 NORTH AMERICA: VACCINE ADJUVANTS MARKET FOR INTRAMUSCULAR ADMINISTRATION, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 42 EUROPE: VACCINE ADJUVANTS MARKET FOR INTRAMUSCULAR ADMINISTRATION, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 43 ASIA PACIFIC: VACCINE ADJUVANTS MARKET FOR INTRAMUSCULAR ADMINISTRATION, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 44 ADVANTAGES AND DISADVANTAGES OF SUBCUTANEOUS ADMINISTRATION TABLE 45 VACCINE ADJUVANTS MARKET FOR SUBCUTANEOUS ADMINISTRATION, BY REGION, 2021-2028 (USD MILLION) TABLE 46 NORTH AMERICA: VACCINE ADJUVANTS MARKET FOR SUBCUTANEOUS ADMINISTRATION, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 47 EUROPE: VACCINE ADJUVANTS MARKET FOR SUBCUTANEOUS ADMINISTRATION, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 48 ASIA PACIFIC: VACCINE ADJUVANTS MARKET FOR SUBCUTANEOUS ADMINISTRATION, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 49 VACCINE ADJUVANTS MARKET FOR OTHER ROUTES OF ADMINISTRATION, BY REGION, 2021-2028 (USD MILLION) TABLE 50 NORTH AMERICA: VACCINE ADJUVANTS MARKET FOR OTHER ROUTES OF ADMINISTRATION, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 51 EUROPE: VACCINE ADJUVANTS MARKET FOR OTHER ROUTES OF ADMINISTRATION, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 52 ASIA PACIFIC: VACCINE ADJUVANTS MARKET FOR OTHER ROUTES OF ADMINISTRATION, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 53 VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2021-2028 (USD MILLION) TABLE 54 VACCINE ADJUVANTS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2021-2028 (USD MILLION) TABLE 55 NORTH AMERICA: VACCINE ADJUVANTS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 56 EUROPE: VACCINE ADJUVANTS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 57 ASIA PACIFIC: VACCINE ADJUVANTS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 58 VACCINE ADJUVANTS MARKET FOR CANCER, BY REGION, 2021-2028 (USD MILLION) TABLE 59 NORTH AMERICA: VACCINE ADJUVANTS MARKET FOR CANCER, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 60 EUROPE: VACCINE ADJUVANTS MARKET FOR CANCER, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 61 ASIA PACIFIC: VACCINE ADJUVANTS MARKET FOR CANCER, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 62 VACCINE ADJUVANTS MARKET FOR OTHER DISEASES, BY REGION, 2021-2028 (USD MILLION) TABLE 63 NORTH AMERICA: VACCINE ADJUVANTS MARKET FOR OTHER DISEASES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 64 EUROPE: VACCINE ADJUVANTS MARKET FOR OTHER DISEASES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 65 ASIA PACIFIC: VACCINE ADJUVANTS MARKET FOR OTHER DISEASES, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 66 VACCINE ADJUVANTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 67 VACCINE ADJUVANTS MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2021-2028 (USD MILLION) TABLE 68 NORTH AMERICA: VACCINE ADJUVANTS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 69 EUROPE: VACCINE ADJUVANTS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 70 ASIA PACIFIC: VACCINE ADJUVANTS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 71 VACCINE ADJUVANTS MARKET FOR COMMERCIAL APPLICATIONS, BY REGION, 2021-2028 (USD MILLION) TABLE 72 NORTH AMERICA: VACCINE ADJUVANTS MARKET FOR COMMERCIAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 73 EUROPE: VACCINE ADJUVANTS MARKET FOR COMMERCIAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 74 ASIA PACIFIC: VACCINE ADJUVANTS MARKET FOR COMMERCIAL APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 75 VACCINE ADJUVANTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 76 HUMAN VACCINE ADJUVANTS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 77 NORTH AMERICA: HUMAN VACCINE ADJUVANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 78 EUROPE: HUMAN VACCINE ADJUVANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 79 ASIA PACIFIC: HUMAN VACCINE ADJUVANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 80 VETERINARY VACCINE ADJUVANTS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 81 NORTH AMERICA: VETERINARY VACCINE ADJUVANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 82 EUROPE: VETERINARY VACCINE ADJUVANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 83 ASIA PACIFIC: VETERINARY VACCINE ADJUVANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 84 VACCINE ADJUVANTS MARKET, BY REGION, 2021-2028 (USD MILLION) TABLE 85 NORTH AMERICA: VACCINE ADJUVANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 86 NORTH AMERICA: VACCINE ADJUVANTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 87 NORTH AMERICA: VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) TABLE 88 NORTH AMERICA: VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2021-2028 (USD MILLION) TABLE 89 NORTH AMERICA: VACCINE ADJUVANTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 90 NORTH AMERICA: VACCINE ADJUVANTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 91 US: VACCINE ADJUVANTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 92 US: VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) TABLE 93 US: VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2021-2028 (USD MILLION) TABLE 94 US: VACCINE ADJUVANTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 95 US: VACCINE ADJUVANTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 96 CANADA: VACCINE ADJUVANTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 97 CANADA: VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) TABLE 98 CANADA: VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2021-2028 (USD MILLION) TABLE 99 CANADA: VACCINE ADJUVANTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 100 CANADA: VACCINE ADJUVANTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 101 EUROPE: VACCINE ADJUVANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 102 EUROPE: VACCINE ADJUVANTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 103 EUROPE: VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) TABLE 104 EUROPE: VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2021-2028 (USD MILLION) TABLE 105 EUROPE: VACCINE ADJUVANTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 106 EUROPE: VACCINE ADJUVANTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 107 GERMANY: VACCINE ADJUVANTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 108 GERMANY: VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) TABLE 109 GERMANY: VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2021-2028 (USD MILLION) TABLE 110 GERMANY: VACCINE ADJUVANTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 111 GERMANY: VACCINE ADJUVANTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 112 UK: VACCINE ADJUVANTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 113 UK: VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) TABLE 114 UK: VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2021-2028 (USD MILLION) TABLE 115 UK: VACCINE ADJUVANTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 116 UK: VACCINE ADJUVANTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 117 FRANCE: VACCINE ADJUVANTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 118 FRANCE: VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) TABLE 119 FRANCE: VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2021-2028 (USD MILLION) TABLE 120 FRANCE: VACCINE ADJUVANTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 121 FRANCE: VACCINE ADJUVANTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 122 ITALY: VACCINE ADJUVANTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 123 ITALY: VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) TABLE 124 ITALY: VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2021-2028 (USD MILLION) TABLE 125 ITALY: VACCINE ADJUVANTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 126 ITALY: VACCINE ADJUVANTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 127 SPAIN: VACCINE ADJUVANTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 128 SPAIN: VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) TABLE 129 SPAIN: VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2021-2028 (USD MILLION) TABLE 130 SPAIN: VACCINE ADJUVANTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 131 SPAIN: VACCINE ADJUVANTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 132 REST OF EUROPE: VACCINE ADJUVANTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 133 REST OF EUROPE: VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) TABLE 134 REST OF EUROPE: VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2021-2028 (USD MILLION) TABLE 135 REST OF EUROPE: VACCINE ADJUVANTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 136 REST OF EUROPE: VACCINE ADJUVANTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 137 ASIA PACIFIC: VACCINE ADJUVANTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) TABLE 138 ASIA PACIFIC: VACCINE ADJUVANTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 139 ASIA PACIFIC: VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) TABLE 140 ASIA PACIFIC: VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2021-2028 (USD MILLION) TABLE 141 ASIA PACIFIC: VACCINE ADJUVANTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 142 ASIA PACIFIC: VACCINE ADJUVANTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 143 CHINA: VACCINE ADJUVANTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 144 CHINA: VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) TABLE 145 CHINA: VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2021-2028 (USD MILLION) TABLE 146 CHINA: VACCINE ADJUVANTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 147 CHINA: VACCINE ADJUVANTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 148 JAPAN: VACCINE ADJUVANTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 149 JAPAN: VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) TABLE 150 JAPAN: VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2021-2028 (USD MILLION) TABLE 151 JAPAN: VACCINE ADJUVANTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 152 JAPAN: VACCINE ADJUVANTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 153 INDIA: VACCINE ADJUVANTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 154 INDIA: VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) TABLE 155 INDIA: VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2021-2028 (USD MILLION) TABLE 156 INDIA: VACCINE ADJUVANTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 157 INDIA: VACCINE ADJUVANTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 158 REST OF ASIA PACIFIC: VACCINE ADJUVANTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 159 REST OF ASIA PACIFIC: VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) TABLE 160 REST OF ASIA PACIFIC: VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2021-2028 (USD MILLION) TABLE 161 REST OF ASIA PACIFIC: VACCINE ADJUVANTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 162 REST OF ASIA PACIFIC: VACCINE ADJUVANTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 163 LATIN AMERICA: VACCINE ADJUVANTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 164 LATIN AMERICA: VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) TABLE 165 LATIN AMERICA: VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2021-2028 (USD MILLION) TABLE 166 LATIN AMERICA: VACCINE ADJUVANTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 167 LATIN AMERICA: VACCINE ADJUVANTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 168 MIDDLE EAST & AFRICA: VACCINE ADJUVANTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION) TABLE 169 MIDDLE EAST & AFRICA: VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (USD MILLION) TABLE 170 MIDDLE EAST & AFRICA: VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2021-2028 (USD MILLION) TABLE 171 MIDDLE EAST & AFRICA: VACCINE ADJUVANTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION) TABLE 172 MIDDLE EAST & AFRICA: VACCINE ADJUVANTS MARKET, BY TYPE, 2021-2028 (USD MILLION) TABLE 173 VACCINE ADJUVANTS MARKET: DEGREE OF COMPETITION TABLE 174 VACCINE ADJUVANTS MARKET: COMPANY PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS TABLE 175 VACCINE ADJUVANTS MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS TABLE 176 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS IN VACCINE ADJUVANTS MARKET TABLE 177 VACCINE ADJUVANTS MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SME PLAYERS TABLE 178 VACCINE ADJUVANTS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-JULY 2023 TABLE 179 VACCINE ADJUVANTS MARKET: DEALS, JANUARY 2021-JULY 2023 TABLE 180 VACCINE ADJUVANTS MARKET: OTHER DEVELOPMENTS, JANUARY 2021-JULY 2023 TABLE 181 DYNAVAX TECHNOLOGIES: BUSINESS OVERVIEW TABLE 182 CRODA INTERNATIONAL PLC: BUSINESS OVERVIEW TABLE 183 GSK PLC: BUSINESS OVERVIEW TABLE 184 SEPPIC (A SUBSIDIARY OF AIR LIQUIDE GROUP): BUSINESS OVERVIEW TABLE 185 NOVAVAX: BUSINESS OVERVIEW TABLE 186 SPI PHARMA (A SUBSIDIARY OF ASSOCIATED BRITISH FOODS PLC): BUSINESS OVERVIEW TABLE 187 AGENUS INC.: BUSINESS OVERVIEW TABLE 188 PHIBRO ANIMAL HEALTH CORPORATION: BUSINESS OVERVIEW TABLE 189 AURORIUM (FORMERLY VERTELLUS): BUSINESS OVERVIEW TABLE 190 MERCK KGAA: BUSINESS OVERVIEW TABLE 191 VAXINE PTY LTD.: BUSINESS OVERVIEW TABLE 192 HAWAII BIOTECH INC.: BUSINESS OVERVIEW TABLE 193 CSL LIMITED: BUSINESS OVERVIEW TABLE 194 OZ BIOSCIENCES: BUSINESS OVERVIEW TABLE 195 INVIVOGEN: BUSINESS OVERVIEW TABLE 196 ALLERGY THERAPEUTICS: BUSINESS OVERVIEW TABLE 197 EUBIOLOGICS CO., LTD.: BUSINESS OVERVIEW TABLE 198 PACIFIC GENETECH LIMITED: BUSINESS OVERVIEW TABLE 199 RIBOXX GMBH: BUSINESS OVERVIEW TABLE 200 CAPTIVATE PHARMACEUTICALS LLC: BUSINESS OVERVIEW
FIGURE 1 RESEARCH DESIGN FIGURE 2 VACCINE ADJUVANTS MARKET: PRIMARY RESPONDENTS FIGURE 3 VACCINE ADJUVANTS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022 FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY EXPERTS FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH FIGURE 7 VACCINE ADJUVANTS MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS FIGURE 8 VACCINE ADJUVANTS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES FIGURE 9 DATA TRIANGULATION METHODOLOGY FIGURE 10 VACCINE ADJUVANTS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) FIGURE 11 VACCINE ADJUVANTS MARKET, BY ROUTE OF ADMINISTRATION, 2023 VS. 2028 (USD MILLION) FIGURE 12 VACCINE ADJUVANTS MARKET, BY DISEASE TYPE, 2023 VS. 2028 (USD MILLION) FIGURE 13 VACCINE ADJUVANTS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) FIGURE 14 VACCINE ADJUVANTS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) FIGURE 15 GEOGRAPHICAL SNAPSHOT OF VACCINE ADJUVANTS MARKET FIGURE 16 RISING PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET GROWTH FIGURE 17 ADJUVANT EMULSIONS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN VACCINE ADJUVANTS MARKET IN 2022 FIGURE 18 ADJUVANT EMULSIONS SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2028 FIGURE 19 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATES FROM 2023 TO 2028 FIGURE 20 VACCINE ADJUVANTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FIGURE 21 PIPELINE OF VACCINE ADJUVANTS FIGURE 22 REVENUE SHIFT AND NEW REVENUE POCKETS FOR VACCINE ADJUVANT PROVIDERS FIGURE 23 VALUE CHAIN ANALYSIS: RAW MATERIAL AND MANUFACTURING PHASES CONTRIBUTE MAXIMUM VALUE FIGURE 24 ECOSYSTEM ANALYSIS FIGURE 25 PATENT APPLICATIONS FOR VACCINE ADJUVANTS, AUGUST 2013-AUGUST 2023 FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF VACCINE ADJUVANTS FIGURE 27 KEY BUYING CRITERIA FOR END USERS FIGURE 28 NORTH AMERICA: VACCINE ADJUVANTS MARKET SNAPSHOT FIGURE 29 ASIA PACIFIC: VACCINE ADJUVANTS MARKET SNAPSHOT FIGURE 30 VACCINE ADJUVANTS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS, 2020-2022 FIGURE 32 VACCINE ADJUVANTS MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2022) FIGURE 33 VACCINE ADJUVANTS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 FIGURE 34 VACCINE ADJUVANTS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 FIGURE 35 DYNAVAX TECHNOLOGIES: COMPANY SNAPSHOT (2022) FIGURE 36 CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT (2022) FIGURE 37 GSK PLC: COMPANY SNAPSHOT (2022) FIGURE 38 SEPPIC (A SUBSIDIARY OF AIR LIQUIDE GROUP): COMPANY SNAPSHOT (2022) FIGURE 39 NOVAVAX: COMPANY SNAPSHOT (2022) FIGURE 40 SPI PHARMA (A SUBSIDIARY OF ASSOCIATED BRITISH FOODS PLC): COMPANY SNAPSHOT (2022) FIGURE 41 AGENUS INC.: COMPANY SNAPSHOT (2022) FIGURE 42 PHIBRO ANIMAL HEALTH CORPORATION: COMPANY SNAPSHOT (2022) FIGURE 43 MERCK KGAA: COMPANY SNAPSHOT (2022) FIGURE 44 CSL LIMITED: COMPANY SNAPSHOT (2022) FIGURE 45 ALLERGY THERAPEUTICS: COMPANY SNAPSHOT (2022)
